Skip to content

Clinical trials

Pulmonary Eosinophilia trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Eosinophilia Country / region: Germany Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20131
20142
20151
20162
20171
20182
20202
20211
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting3
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
AstraZeneca4
Teva Branded Pharmaceutical Products R&D, Inc.2
Areteia Therapeutics1
GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.1
Hannover Medical School1
Johannes Gutenberg University Mainz1
Kymera Therapeutics, Inc.1
Matthias Griese1
University of Rostock1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Eosinophilia18
Asthma10
Lung Diseases, Interstitial1
Nasal Polyps1
Pulmonary Alveolar Proteinosis1
Pulmonary Fibrosis1
Respiratory Distress Syndrome, Newborn1

Trials

Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.